Home

Elevation Oncology, Inc. - Common stock (ELEV)

0.6932
+0.0266 (3.99%)

Elevation Oncology Inc is a biopharmaceutical company focused on developing targeted therapies for patients with genomically defined cancers

The company is dedicated to understanding the unique genetic drivers of these diseases and aims to create innovative treatment options that address unmet medical needs. By leveraging its expertise in precision medicine and oncology, Elevation Oncology works to advance its clinical pipeline, providing hope to patients with rare and challenging cancer types through personalized and effective therapeutic strategies.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Elevation Oncology, Inc. - Common stock publicly traded?
Yes, Elevation Oncology, Inc. - Common stock is publicly traded.
What exchange does Elevation Oncology, Inc. - Common stock trade on?
Elevation Oncology, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Elevation Oncology, Inc. - Common stock?
The ticker symbol for Elevation Oncology, Inc. - Common stock is ELEV on the Nasdaq Stock Market
What is the current price of Elevation Oncology, Inc. - Common stock?
The current price of Elevation Oncology, Inc. - Common stock is 0.6932
When was Elevation Oncology, Inc. - Common stock last traded?
The last trade of Elevation Oncology, Inc. - Common stock was at 4:00 pm EST on January 31st, 2025